keyword
https://read.qxmd.com/read/38489039/the-impact-of-perioperative-risk-factors-on-long-term-survival-after-radical-cystectomy-a-prospective-high-volume-cohort-study
#21
JOURNAL ARTICLE
Nikolaos Pyrgidis, Gerald B Schulz, Yannic Volz, Benedikt Ebner, Severin Rodler, Thilo Westhofen, Lennert Eismann, Julian Marcon, Christian G Stief, Friedrich Jokisch
INTRODUCTION: Radical cystectomy (RC) is the gold standard for muscle-invasive bladder cancer. Nevertheless, RC is associated with substantial perioperative morbidity and mortality. We aimed to evaluate the role of important perioperative risk factors in predicting long-term survival after RC. METHODS: An analysis of the prospective cohort of patients undergoing open RC from 2004 to 2023 at our center was performed. Patients who died within one month after RC were excluded from the study...
March 15, 2024: World Journal of Urology
https://read.qxmd.com/read/38484344/mortality-in-patients-with-hematological-malignancies-febrile-neutropenia-and-septic-shock
#22
JOURNAL ARTICLE
Beda Islas-Muñoz, Patricia Volkow-Fernández, Jorge Silva-Zamora, Ana Ramírez-Ibarguen, Patricia Cornejo-Juárez
INTRODUCTION: Patients with severe neutropenia who develop septic shock (SS) have high mortality. This study aimed to evaluate the risk factors and mortality of SS in patients with HM and febrile neutropenia. METHODOLOGY: We included all patients with hematological malignancies (HM) who presented fever and severe neutropenia, admitted to an oncological tertiary care center in Mexico City for one year. RESULTS: Two hundred ninety-two episodes of fever and severe neutropenia were documented; 68 patients (23...
February 29, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38476634/a-case-of-metastatic-choriocarcinoma-related-paraneoplastic-thyroid-storm
#23
Nidhi Gupta, Lauren Graham, Matthew Carpenter, Gunjan Y Gandhi
Thyroid storm due to gestational trophoblastic disease (GTD) with metastatic choriocarcinoma is a rare but potentially life-threatening endocrine emergency. We report on a woman with molar pregnancy and metastatic choriocarcinoma who presented with thyroid storm (Burch-Wartofsky point scale of 45) a few weeks after the evacuation of GTD. She was initially managed with intravenous hydrocortisone, oral propylthiouracil (PTU), and esmolol infusion. After stabilization in the intensive care unit, 10 cycles of chemotherapy with etoposide, methotrexate, leucovorin, dactinomycin, and cyclophosphamide (EMA-CO) were initiated for stage 4 choriocarcinoma with brain and lung metastases...
March 2024: JCEM Case Rep
https://read.qxmd.com/read/38466410/pregnancy-and-neonatal-outcomes-in-25-pregnant-women-diagnosed-with-new-onset-acute-myeloid-leukemia-during-pregnancy
#24
JOURNAL ARTICLE
Jing Ding, YiHan Xiao, Jie Fu, Guoli Liu, Shanyamei Huang, Xiaodong Mo
PURPOSE: The aim was to analyze the pregnancy and neonatal outcomes of pregnant women with new- onset acute myeloid leukemia (AML) diagnosed during pregnancy. METHODS: In this retrospective study 25 pregnant women who were diagnosed with new-onset AML during pregnancy from January 2010 to January 2021 were enrolled. RESULTS: A total of 4, 13 and 8 pregnant women with new-onset AML were diagnosed during the first, second, and third trimesters, respectively...
March 11, 2024: Archives of Gynecology and Obstetrics
https://read.qxmd.com/read/38460433/efficacy-and-safety-of-mitoxantrone-etoposide-and-cytarabine-for-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia
#25
JOURNAL ARTICLE
Sharon Zhong, Heena Kurish, Robert Walchack, Hong Li, Jessi Edwards, Abhay Singh, Anjali Advani
BACKGROUND/RATIONALE: Most patients with acute myeloid leukemia (AML) develop relapsed or refractory (R/R) disease after receiving initial induction chemotherapy. Salvage chemotherapy followed by allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only curative therapy for R/R AML. Mitoxantrone, etoposide, and cytarabine (MEC) is the current standard of care salvage regimen for R/R AML at Cleveland Clinic. The primary objective was to determine the overall remission rate (ORR: defined as patients achieving complete remission (CR) or complete remission with incomplete hematologic recovery (CRi)) in R/R AML patients who received MEC...
April 2024: Leukemia Research
https://read.qxmd.com/read/38450451/utilization-of-medical-interventions-in-hospitalized-mexican-adults-with-cancer-at-the-end-of-life-in-a-referral-hospital-the-importance-of-early-palliative-care
#26
JOURNAL ARTICLE
Silvia Rosa Allende-Pérez, Nadia Cristina Sandoval-Carrera, Leticia Asencio-Huertas, Oscar Rodríguez-Mayoral, Jacob Jonatan Cruz-Sánchez, Emma Verástegui-Avilés
OBJECTIVES: To investigate the impact of early vs. late palliative care (PC) on the frequency of admissions to acute hospital settings and the utilization of end-of-life (EoL) interventions in cancer decedents. METHODS: In this single-center, cross-sectional study, we examined the frequency of intensive care unit (ICU) and emergency department (ED) admissions among adult cancer decedents between 2018 and 2022 in a referral hospital in México. Additionally, we assessed EoL medical interventions, categorizing patients into 3 groups: those who received early PC (EPC), late PC (LPC), and those who did not receive PC (NPC)...
March 7, 2024: Palliative & Supportive Care
https://read.qxmd.com/read/38430844/baseline-immune-status-and-the-effectiveness-of-response-to-enteral-nutrition-among-icu-patients-with-covid-19-an-observational-retrospective-study
#27
JOURNAL ARTICLE
Yao Yin, Yijing Li, Yan Liu, Chaofeng Fan, Yan Jiang
OBJECTIVES: This study aimed to compare how immunocompromised and immunocompetent patients responded differently to enteral nutrition (EN) support in intensive care units (ICUs) during the COVID-19 pandemic, including serum nutritional biomarkers, inflammatory biomarkers, gastrointestinal (GI) intolerance symptoms, and clinical outcomes. METHODS: An observational, retrospective study was conducted in the ICUs of a teaching hospital in southwest China. We recruited a convenience sample of 154 patients between December 2022 and February 2023...
February 8, 2024: Nutrition
https://read.qxmd.com/read/38411988/impact-of-hypoalbuminemia-on-clinical-outcomes-among-patients-with-obesity-treated-with-ceftriaxone
#28
JOURNAL ARTICLE
Kellie Arensman Hannan, Evan Draper, Kristin C Cole, Jack Mc Hugh, Christina G Rivera, Omar Abu Saleh
The use of ceftriaxone, a highly protein-bound drug, in the setting of hypoalbuminemia may result in suboptimal drug exposure. Patients with obesity also exhibit higher absolute drug clearance. We aimed to evaluate the impact of hypoalbuminemia on clinical success among hospitalized adults with obesity who were treated with ceftriaxone. This retrospective review included adult inpatients with weight >100 kg or body mass index >40 kg/m2 who received ceftriaxone 2 g intravenously every 12 hours for at least 72 hours...
April 3, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38406084/blueberry-muffin-syndrome-and-hyperleukocytosis-in-a-newborn-a-diagnostic-challenge
#29
Beatriz Teixeira, Ana Losa, Andreia Meireles, Ana Lachado, Isabel Couto Guerra, Susana Machado, Lídia Branco, Paulo Paulino, Catarina Lau, Natália Oliva-Teles, Carlos Mendes, Tereza Oliva, Liliana Pinho, Luísa Neiva, Elisa Proença
Blueberry muffin syndrome (BMS) in neonates, characterized by widespread nodular lesions, presents diagnostic challenges due to its diverse etiologies. Hyperleukocytosis, with leukocyte counts exceeding 100,000/μL, is a rare phenomenon associated with severe complications in neonates. Congenital leukemia (CL), a rare diagnosis within the first month of life, is linked to high mortality. This case report presents a unique case of BMS with hyperleukocytosis as the initial presentation of CL. A full-term male newborn, born after an uncomplicated pregnancy, except for Kell isoimmunization, with an Apgar score of 9/10, and an irrelevant family history, showed widespread purple nodules consistent with BMS at birth...
January 2024: Curēus
https://read.qxmd.com/read/38398112/association-between-inappropriate-end-of-life-cancer-care-and-specialist-palliative-care-a-retrospective-observational-study-in-two-acute-care-hospitals
#30
JOURNAL ARTICLE
Manon S Boddaert, Heidi P Fransen, Ellen J M de Nijs, Dagmar van Gerven, Leontine E A Spierings, Natasja J H Raijmakers, Yvette M van der Linden
A substantial number of patients with life-threatening illnesses like cancer receive inappropriate end-of-life care. Improving their quality of end-of-life care is a priority for patients and their families and for public health. To investigate the association between provision, timing, and initial setting of hospital-based specialist palliative care and potentially inappropriate end-of-life care for patients with cancer in two acute care hospitals in the Netherlands, we conducted a retrospective observational study using hospital administrative databases...
February 8, 2024: Cancers
https://read.qxmd.com/read/38392055/acute-diabetes-related-complications-in-patients-receiving-chemoradiotherapy-for-head-and-neck-cancer
#31
JOURNAL ARTICLE
Rhiannon Mellor, Christian M Girgis, Anthony Rodrigues, Charley Chen, Sonia Cuan, Parvind Gambhir, Lakmalie Perera, Michael Veness, Purnima Sundaresan, Bo Gao
UNLABELLED: Patients with cancer and diabetes face unique challenges. Limited data are available on diabetes management in patients undergoing concurrent chemoradiotherapy (CCRT), a curative intent anticancer therapy commonly associated with glucocorticoid administration, weight fluctuations and enteral feeds. This retrospective case-control study examined the real-world incidence of acute diabetes-related complications in patients with head and neck cancer receiving CCRT, along with the impact of diabetes on CCRT tolerance and outcomes...
February 1, 2024: Current Oncology
https://read.qxmd.com/read/38387031/palliative-care-interventions-and-end-of-life-care-for-patients-with-metastatic-breast-cancer-a-multicentre-analysis
#32
JOURNAL ARTICLE
Elisabeth Lucchi, Frédérique Berger, Maude Milder, Jean-Marie Commer, Sophie Morin, Geraldine Capodano, Muriel Thomaso, Anne Fogliarini, Nathalie Bremaud, Aline Henry, Benedicte Mastroianni, Gisele Chvetzoff, Carole Bouleuc
BACKGROUND: The aim of this study was to describe the implementation of integrated palliative care (PC) and the intensity of care in the last 3 months before death for patients with metastatic breast cancer. MATERIALS AND METHODS: We conducted a multicentric study of all adult patients with metastatic breast cancer who died over a 4-month period. Complete data were collected and checked from clinical records, including PC interventions and criteria regarding EOL care aggressiveness...
February 22, 2024: Oncologist
https://read.qxmd.com/read/38378162/oncology-and-palliative-care-integration-model-a-cost-analysis-study-in-a-brazilian-hospital-setting
#33
JOURNAL ARTICLE
Tânia V V Guimarães, Alessandro G Campolina, Luciana M Rozman, Toshio Chiba, Patrícia C de Soárez, Maria D P Estevez Diz
Background: In 2019, the São Paulo State Cancer Institute (ICESP) implemented a novel model integrating Oncology with Palliative Care specialists. We evaluated the impact of this model on healthcare resource utilization and costs. Methods: We analyzed data from all patients who passed away in February (1 month prior to implementation) and November (8 months after model implementation group) at ICESP, Brazil. Healthcare utilization data, including emergency department visits, hospital and intensive care unit admissions, chemotherapy, and radiotherapy use, were retrieved from Electronic Medical Records...
February 20, 2024: American Journal of Hospice & Palliative Care
https://read.qxmd.com/read/38367932/ensitrelvir-in-patients-with-sars-cov-2-a-retrospective-chart-review
#34
JOURNAL ARTICLE
Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, Masayuki Seki, Tomoki Mizuno, Takuhiro Sonoyama
Antivirals with proven effectiveness against the Omicron SARS-CoV-2 variant are required for COVID-19 treatment in hospitalized patients, particularly those with severe underlying conditions. Ensitrelvir, a 3C-like protease inhibitor, received emergency approval in Japan in November 2022, based on evidence of rapid symptom resolution in non-hospitalized patients, but confirmation of its effectiveness in hospitalized patients is lacking. This retrospective chart review reports outcomes for all patients who received ensitrelvir whilst hospitalized with SARS-CoV-2 infection at Rinku General Medical Center, Japan (November 2022-April 2023)...
February 15, 2024: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/38366368/lower-blood-levels-of-isavuconazole-in-critically-ill-patients-compared-with-other-populations-possible-need-for-therapeutic-drug-monitoring
#35
JOURNAL ARTICLE
Malgorzata Mikulska, Monica Melchio, Alessio Signori, Nadir Ullah, Franca Miletich, Chiara Sepulcri, Alessandro Limongelli, Daniele Roberto Giacobbe, Elisa Balletto, Chiara Russo, Laura Magnasco, Antonio Vena, Carmen Di Grazia, Anna Maria Raiola, Federica Portunato, Chiara Dentone, Denise Battaglini, Lorenzo Ball, Chiara Robba, Emanuele Angelucci, Iole Brunetti, Matteo Bassetti
BACKGROUND: Isavuconazole is first-line treatment of invasive aspergillosis. Therapeutic drug monitoring (TDM) is deemed not necessary, since most patients reached therapeutic levels (>1 mg/L) in large studies. Low levels were reported in some critically ill patients admitted to the ICU. The aim was to compare isavuconazole levels between critically ill and non-critically ill patients. MATERIALS AND METHODS: Retrospective analysis of data from all patients treated with standard-dose isavuconazole between 1 January 2019 and 26 October 2022 was performed...
February 15, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38363632/pan-indian-clinical-registry-of-invasive-fungal-infections-among-patients-in-the-intensive-care-unit-protocol-for-a-multicentric-prospective-study
#36
JOURNAL ARTICLE
Anup Kumar Ojha, Venencia Albert, Saurabh Sharma, Vinaykumar Hallur, Gagandeep Singh, Umabala Pamidimukkala, Kh Jitenkumar Singh, Harleen Kaur, Tadepalli Karuna, Jayanthi Savio, Reema Nath, Immaculata Xess, Prashant Gupta, Anjali Shetty, Madhuchhanda Das
BACKGROUND: Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India...
February 16, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38363100/radial-forearm-free-flap-reconstruction-in-a-3-month-old-patient-with-undifferentiated-pharyngeal-sarcoma
#37
Theodore Lam, Eric Levi, Jacson Shen, Daniel Wilks, William Alexander
There is minimal information regarding free tissue transfers in very young infants, especially those less than a year old. It is often thought that that age remains a limit to free tissue transfers, with younger patients having smaller vessels, making the operation technically challenging. In this case report, we discuss the youngest and smallest recorded case of a free flap reconstruction. A 3-month-old patient with a malignant parapharyngeal undifferentiated round cell sarcoma underwent a resection and reconstruction with a radial forearm free flap (RFFF)...
February 2024: Microsurgery
https://read.qxmd.com/read/38344604/t-cell-acute-lymphoblastic-leukemia-in-crisis-hyperleukocytosis-tumor-lysis-syndrome-and-innovative-approaches
#38
Gordon White, Mariel Duchow, Levy Amar
T-cell acute lymphoblastic leukemia (T-ALL) is a rare hematologic malignancy with a unique set of clinical challenges when it occurs in adults. This case report presents the complex management of a 32-year-old male with T-ALL who developed symptomatic hyperleukocytosis and tumor lysis syndrome. Upon presentation, the patient exhibited a constellation of critical clinical and laboratory findings, including leukocytosis, anemia, thrombocytopenia, hyperkalemia, high-anion gap metabolic acidosis, and acute kidney injury...
January 2024: Curēus
https://read.qxmd.com/read/38342997/clinical-outcomes-of-hypomethylating-agents-plus-venetoclax-as-frontline-treatment-in-patients-75%C3%A2-years-and-older-with-acute-myeloid-leukemia-real-world-data-from-eight-us-academic-centers
#39
JOURNAL ARTICLE
Yasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, Rory M Shallis, Andrew H Matthews, Talha Badar, Emily M Geramita, Vamsi K Kota, Alok Swaroop, Peter Doukas, Danielle Bradshaw, Irene B Helenowski, Yingzhe Liu, Hui Zhang, Annie Im, Mark R Litzow, Alexander E Perl, Ehab Atallah, Jessica K Altman
Venetoclax (VEN) combined with hypomethylating agents (HMAs) is the standard of care for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) unfit for intensive chemotherapy. To date, real-world data published on HMAs plus VEN have been either single-center studies or using community-based electronic databases with limited details on mutational landscape, tolerability, and treatment patterns in elderly patients. Therefore, we conducted a multicenter retrospective study to assess the real-world experience of 204 elderly patients (≥75 years) with newly diagnosed AML treated with HMAs plus VEN from eight academic centers in the United States...
February 11, 2024: American Journal of Hematology
https://read.qxmd.com/read/38340644/effects-of-hospice-shared-care-on-terminal-cancer-patients-in-taiwan-a-hospital-based-observational-study
#40
JOURNAL ARTICLE
Hui-Wen Huang, Chun-Yu Liu, Tao-Hsin Tung, Li-Ni Liu
PURPOSE: To assess how hospice-shared care (HSC) affected the likelihood of aggressive medical treatments and the life quality among terminal cancer patients. METHODS: In the first part, a cohort of 160 late-stage cancer patients who died in non-hospice wards were identified to review their charts in their last 22 days before death. In the second part, a total of 19 late-stage cancer patients with clear consciousness admitted to non-hospice wards were identified to investigate their quality of life for the final 2 weeks before death...
February 5, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
keyword
keyword
91007
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.